Raghuram Selvaraju

H.C. Wainwright & Co.

Recent Articles about Verona Pharma Plc

Biopharma's New Drug for COPD Likely to be Approved 04/22/2024

Characteristics of the Buy-rated company's lead candidate make it "an intriguing commercial prospect," noted an H.C. Wainwright & Co. report.